Form 4 holding
Executive Vice President, Global R&D and Chief Medical Officer.
TEVA PHARMACEUTICAL INDUSTRIES LTD
- Security class
- Ordinary Shares
- Shares / value
- 134,877
- Estimated value
- $4,703,929
- Report date
- 03 Aug 2026
- Price
- $34.88
- Ownership
- Direct